PMGC (NASDAQ:ELAB – Get Free Report) and Cannabis Wheaton Income (OTCMKTS:CBWTF – Get Free Report) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership.
Earnings and Valuation
This table compares PMGC and Cannabis Wheaton Income”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| PMGC | $590,000.00 | 9.14 | -$7.75 million | ($130.60) | -0.05 |
| Cannabis Wheaton Income | $108.41 million | 1.67 | $29.96 million | $0.02 | 6.38 |
Insider and Institutional Ownership
22.2% of PMGC shares are owned by institutional investors. 0.0% of PMGC shares are owned by insiders. Comparatively, 4.6% of Cannabis Wheaton Income shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Volatility & Risk
PMGC has a beta of -0.25, meaning that its stock price is 125% less volatile than the S&P 500. Comparatively, Cannabis Wheaton Income has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500.
Profitability
This table compares PMGC and Cannabis Wheaton Income’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| PMGC | -522.92% | -118.83% | -60.03% |
| Cannabis Wheaton Income | 20.99% | 19.84% | 12.26% |
Analyst Recommendations
This is a summary of current ratings and price targets for PMGC and Cannabis Wheaton Income, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| PMGC | 1 | 0 | 0 | 0 | 1.00 |
| Cannabis Wheaton Income | 0 | 0 | 0 | 0 | 0.00 |
Summary
Cannabis Wheaton Income beats PMGC on 9 of the 12 factors compared between the two stocks.
About PMGC
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.
About Cannabis Wheaton Income
Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. It focuses on developing, manufacturing, and distributing cannabis products for wellness and recreational consumers. The company offers cannabis products under various forms, including vape catridges, infused pre-rolls, pre-rolled, vape pens, milled and dried flower, concentrates, chocolates, soft chews, oil drops, capsules, and topicals under the KOLAB PROJECT, Dosecann, BACK FORTY, Foray, and Parcel brand names. It sells its products through supply arrangements with provincial control boards and distributors, medical cannabis sales channels, and retailers, as well as to authorized wholesalers. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. The company was incorporated in 1987 and is headquartered in Toronto, Canada.
Receive News & Ratings for PMGC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMGC and related companies with MarketBeat.com's FREE daily email newsletter.
